Perseus Proteomics Inc.

4882・Growth Market・Pharmaceuticals

Official website

Perseus Proteomics Inc.

4882・Growth Market・Pharmaceuticals

Official website

Perseus Proteomics Inc.4882

Reference Indicators

Market Cap

26¥100M

P/E (Forecast)

—

P/B

2.3x

Dividend Yield (Forecast)

0.00%

ROE

-63.1%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	71	94	100	120	135
Cost of Sales	4	7	12	16	19
Gross Profit	67	86	87	104	116
SG&A Expenses	539	784	982	930	861
Operating Income	-472	-697	-894	-826	-744
Non-operating Income	9	8	21	3	72
Non-operating Expenses	18	0	5	7	6
Ordinary Income	-481	-689	-879	-829	-678
Extraordinary Income	2	—	0	—	—
Extraordinary Losses	117	95	223	72	37
Pre-tax Income	-597	-785	-1,102	-902	-716
Income Taxes	1	1	1	2	1
Net Income	-599	-786	-1,104	-904	-718
EBITDA	-469	-692	-891	-823	-744
Gross Margin	94.2%	91.9%	87.3%	86.4%	85.7%
Operating Margin	-656.4%	-740.7%	-891.1%	-686.5%	-549.8%
ROA	-18.1%	-30.7%	-65.2%	-49.7%	-44.2%
ROE	-19.0%	-33.3%	-83.4%	-66.9%	-63.1%